Global Iguratimod Market Growth 2022-2028
- LP 4768461
- 70 Pages
- January 2022
- Pharmaceuticals
The United States Iguratimod market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Iguratimod market, reaching US$ million by the year 2028. As for the Europe Iguratimod landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Iguratimod players cover Simcere Pharmaceutical, Toyama Chemical, Eisai, and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Iguratimod market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
14 Pcs/Box
100 Pcs/Box
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Antirheumatic
Immunoregulation
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Simcere Pharmaceutical
Toyama Chemical
Eisai
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Iguratimod Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Iguratimod by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Iguratimod by Country/Region, 2017, 2022 & 2028
2.2 Iguratimod Segment by Type
2.2.1 14 Pcs/Box
2.2.2 100 Pcs/Box
2.3 Iguratimod Sales by Type
2.3.1 Global Iguratimod Sales Market Share by Type (2017-2022)
2.3.2 Global Iguratimod Revenue and Market Share by Type (2017-2022)
2.3.3 Global Iguratimod Sale Price by Type (2017-2022)
2.4 Iguratimod Segment by Application
2.4.1 Antirheumatic
2.4.2 Immunoregulation
2.4.3 Other
2.5 Iguratimod Sales by Application
2.5.1 Global Iguratimod Sale Market Share by Application (2017-2022)
2.5.2 Global Iguratimod Revenue and Market Share by Application (2017-2022)
2.5.3 Global Iguratimod Sale Price by Application (2017-2022)
3 Global Iguratimod by Company
3.1 Global Iguratimod Breakdown Data by Company
3.1.1 Global Iguratimod Annual Sales by Company (2020-2022)
3.1.2 Global Iguratimod Sales Market Share by Company (2020-2022)
3.2 Global Iguratimod Annual Revenue by Company (2020-2022)
3.2.1 Global Iguratimod Revenue by Company (2020-2022)
3.2.2 Global Iguratimod Revenue Market Share by Company (2020-2022)
3.3 Global Iguratimod Sale Price by Company
3.4 Key Manufacturers Iguratimod Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Iguratimod Product Location Distribution
3.4.2 Players Iguratimod Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Iguratimod by Geographic Region
4.1 World Historic Iguratimod Market Size by Geographic Region (2017-2022)
4.1.1 Global Iguratimod Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Iguratimod Annual Revenue by Geographic Region
4.2 World Historic Iguratimod Market Size by Country/Region (2017-2022)
4.2.1 Global Iguratimod Annual Sales by Country/Region (2017-2022)
4.2.2 Global Iguratimod Annual Revenue by Country/Region
4.3 Americas Iguratimod Sales Growth
4.4 APAC Iguratimod Sales Growth
4.5 Europe Iguratimod Sales Growth
4.6 Middle East & Africa Iguratimod Sales Growth
5 Americas
5.1 Americas Iguratimod Sales by Country
5.1.1 Americas Iguratimod Sales by Country (2017-2022)
5.1.2 Americas Iguratimod Revenue by Country (2017-2022)
5.2 Americas Iguratimod Sales by Type
5.3 Americas Iguratimod Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Iguratimod Sales by Region
6.1.1 APAC Iguratimod Sales by Region (2017-2022)
6.1.2 APAC Iguratimod Revenue by Region (2017-2022)
6.2 APAC Iguratimod Sales by Type
6.3 APAC Iguratimod Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Iguratimod by Country
7.1.1 Europe Iguratimod Sales by Country (2017-2022)
7.1.2 Europe Iguratimod Revenue by Country (2017-2022)
7.2 Europe Iguratimod Sales by Type
7.3 Europe Iguratimod Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Iguratimod by Country
8.1.1 Middle East & Africa Iguratimod Sales by Country (2017-2022)
8.1.2 Middle East & Africa Iguratimod Revenue by Country (2017-2022)
8.2 Middle East & Africa Iguratimod Sales by Type
8.3 Middle East & Africa Iguratimod Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Iguratimod
10.3 Manufacturing Process Analysis of Iguratimod
10.4 Industry Chain Structure of Iguratimod
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Iguratimod Distributors
11.3 Iguratimod Customer
12 World Forecast Review for Iguratimod by Geographic Region
12.1 Global Iguratimod Market Size Forecast by Region
12.1.1 Global Iguratimod Forecast by Region (2023-2028)
12.1.2 Global Iguratimod Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Iguratimod Forecast by Type
12.7 Global Iguratimod Forecast by Application
13 Key Players Analysis
13.1 Simcere Pharmaceutical
13.1.1 Simcere Pharmaceutical Company Information
13.1.2 Simcere Pharmaceutical Iguratimod Product Offered
13.1.3 Simcere Pharmaceutical Iguratimod Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Simcere Pharmaceutical Main Business Overview
13.1.5 Simcere Pharmaceutical Latest Developments
13.2 Toyama Chemical
13.2.1 Toyama Chemical Company Information
13.2.2 Toyama Chemical Iguratimod Product Offered
13.2.3 Toyama Chemical Iguratimod Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Toyama Chemical Main Business Overview
13.2.5 Toyama Chemical Latest Developments
13.3 Eisai
13.3.1 Eisai Company Information
13.3.2 Eisai Iguratimod Product Offered
13.3.3 Eisai Iguratimod Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Eisai Main Business Overview
13.3.5 Eisai Latest Developments
14 Research Findings and Conclusion
Table 1. Iguratimod Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Iguratimod Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 14 Pcs/Box
Table 4. Major Players of 100 Pcs/Box
Table 5. Global Iguratimod Sales by Type (2017-2022) & (K Pcs)
Table 6. Global Iguratimod Sales Market Share by Type (2017-2022)
Table 7. Global Iguratimod Revenue by Type (2017-2022) & ($ million)
Table 8. Global Iguratimod Revenue Market Share by Type (2017-2022)
Table 9. Global Iguratimod Sale Price by Type (2017-2022) & (USD/Pcs)
Table 10. Global Iguratimod Sales by Application (2017-2022) & (K Pcs)
Table 11. Global Iguratimod Sales Market Share by Application (2017-2022)
Table 12. Global Iguratimod Revenue by Application (2017-2022)
Table 13. Global Iguratimod Revenue Market Share by Application (2017-2022)
Table 14. Global Iguratimod Sale Price by Application (2017-2022) & (USD/Pcs)
Table 15. Global Iguratimod Sales by Company (2020-2022) & (K Pcs)
Table 16. Global Iguratimod Sales Market Share by Company (2020-2022)
Table 17. Global Iguratimod Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Iguratimod Revenue Market Share by Company (2020-2022)
Table 19. Global Iguratimod Sale Price by Company (2020-2022) & (USD/Pcs)
Table 20. Key Manufacturers Iguratimod Producing Area Distribution and Sales Area
Table 21. Players Iguratimod Products Offered
Table 22. Iguratimod Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Iguratimod Sales by Geographic Region (2017-2022) & (K Pcs)
Table 26. Global Iguratimod Sales Market Share Geographic Region (2017-2022)
Table 27. Global Iguratimod Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Iguratimod Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Iguratimod Sales by Country/Region (2017-2022) & (K Pcs)
Table 30. Global Iguratimod Sales Market Share by Country/Region (2017-2022)
Table 31. Global Iguratimod Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Iguratimod Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Iguratimod Sales by Country (2017-2022) & (K Pcs)
Table 34. Americas Iguratimod Sales Market Share by Country (2017-2022)
Table 35. Americas Iguratimod Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Iguratimod Revenue Market Share by Country (2017-2022)
Table 37. Americas Iguratimod Sales by Type (2017-2022) & (K Pcs)
Table 38. Americas Iguratimod Sales Market Share by Type (2017-2022)
Table 39. Americas Iguratimod Sales by Application (2017-2022) & (K Pcs)
Table 40. Americas Iguratimod Sales Market Share by Application (2017-2022)
Table 41. APAC Iguratimod Sales by Region (2017-2022) & (K Pcs)
Table 42. APAC Iguratimod Sales Market Share by Region (2017-2022)
Table 43. APAC Iguratimod Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Iguratimod Revenue Market Share by Region (2017-2022)
Table 45. APAC Iguratimod Sales by Type (2017-2022) & (K Pcs)
Table 46. APAC Iguratimod Sales Market Share by Type (2017-2022)
Table 47. APAC Iguratimod Sales by Application (2017-2022) & (K Pcs)
Table 48. APAC Iguratimod Sales Market Share by Application (2017-2022)
Table 49. Europe Iguratimod Sales by Country (2017-2022) & (K Pcs)
Table 50. Europe Iguratimod Sales Market Share by Country (2017-2022)
Table 51. Europe Iguratimod Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Iguratimod Revenue Market Share by Country (2017-2022)
Table 53. Europe Iguratimod Sales by Type (2017-2022) & (K Pcs)
Table 54. Europe Iguratimod Sales Market Share by Type (2017-2022)
Table 55. Europe Iguratimod Sales by Application (2017-2022) & (K Pcs)
Table 56. Europe Iguratimod Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Iguratimod Sales by Country (2017-2022) & (K Pcs)
Table 58. Middle East & Africa Iguratimod Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Iguratimod Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Iguratimod Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Iguratimod Sales by Type (2017-2022) & (K Pcs)
Table 62. Middle East & Africa Iguratimod Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Iguratimod Sales by Application (2017-2022) & (K Pcs)
Table 64. Middle East & Africa Iguratimod Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Iguratimod
Table 66. Key Market Challenges & Risks of Iguratimod
Table 67. Key Industry Trends of Iguratimod
Table 68. Iguratimod Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Iguratimod Distributors List
Table 71. Iguratimod Customer List
Table 72. Global Iguratimod Sales Forecast by Region (2023-2028) & (K Pcs)
Table 73. Global Iguratimod Sales Market Forecast by Region
Table 74. Global Iguratimod Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Iguratimod Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Iguratimod Sales Forecast by Country (2023-2028) & (K Pcs)
Table 77. Americas Iguratimod Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Iguratimod Sales Forecast by Region (2023-2028) & (K Pcs)
Table 79. APAC Iguratimod Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Iguratimod Sales Forecast by Country (2023-2028) & (K Pcs)
Table 81. Europe Iguratimod Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Iguratimod Sales Forecast by Country (2023-2028) & (K Pcs)
Table 83. Middle East & Africa Iguratimod Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Iguratimod Sales Forecast by Type (2023-2028) & (K Pcs)
Table 85. Global Iguratimod Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Iguratimod Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Iguratimod Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Iguratimod Sales Forecast by Application (2023-2028) & (K Pcs)
Table 89. Global Iguratimod Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Iguratimod Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Iguratimod Revenue Market Share Forecast by Application (2023-2028)
Table 92. Simcere Pharmaceutical Basic Information, Iguratimod Manufacturing Base, Sales Area and Its Competitors
Table 93. Simcere Pharmaceutical Iguratimod Product Offered
Table 94. Simcere Pharmaceutical Iguratimod Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 95. Simcere Pharmaceutical Main Business
Table 96. Simcere Pharmaceutical Latest Developments
Table 97. Toyama Chemical Basic Information, Iguratimod Manufacturing Base, Sales Area and Its Competitors
Table 98. Toyama Chemical Iguratimod Product Offered
Table 99. Toyama Chemical Iguratimod Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 100. Toyama Chemical Main Business
Table 101. Toyama Chemical Latest Developments
Table 102. Eisai Basic Information, Iguratimod Manufacturing Base, Sales Area and Its Competitors
Table 103. Eisai Iguratimod Product Offered
Table 104. Eisai Iguratimod Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 105. Eisai Main Business
Table 106. Eisai Latest Developments
List of Figures
Figure 1. Picture of Iguratimod
Figure 2. Iguratimod Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Iguratimod Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Iguratimod Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Iguratimod Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 14 Pcs/Box
Figure 10. Product Picture of 100 Pcs/Box
Figure 11. Global Iguratimod Sales Market Share by Type in 2021
Figure 12. Global Iguratimod Revenue Market Share by Type (2017-2022)
Figure 13. Iguratimod Consumed in Antirheumatic
Figure 14. Global Iguratimod Market: Antirheumatic (2017-2022) & (K Pcs)
Figure 15. Iguratimod Consumed in Immunoregulation
Figure 16. Global Iguratimod Market: Immunoregulation (2017-2022) & (K Pcs)
Figure 17. Iguratimod Consumed in Other
Figure 18. Global Iguratimod Market: Other (2017-2022) & (K Pcs)
Figure 19. Global Iguratimod Sales Market Share by Application (2017-2022)
Figure 20. Global Iguratimod Revenue Market Share by Application in 2021
Figure 21. Iguratimod Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Iguratimod Revenue Market Share by Company in 2021
Figure 23. Global Iguratimod Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Iguratimod Revenue Market Share by Geographic Region in 2021
Figure 25. Global Iguratimod Sales Market Share by Region (2017-2022)
Figure 26. Global Iguratimod Revenue Market Share by Country/Region in 2021
Figure 27. Americas Iguratimod Sales 2017-2022 (K Pcs)
Figure 28. Americas Iguratimod Revenue 2017-2022 ($ Millions)
Figure 29. APAC Iguratimod Sales 2017-2022 (K Pcs)
Figure 30. APAC Iguratimod Revenue 2017-2022 ($ Millions)
Figure 31. Europe Iguratimod Sales 2017-2022 (K Pcs)
Figure 32. Europe Iguratimod Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Iguratimod Sales 2017-2022 (K Pcs)
Figure 34. Middle East & Africa Iguratimod Revenue 2017-2022 ($ Millions)
Figure 35. Americas Iguratimod Sales Market Share by Country in 2021
Figure 36. Americas Iguratimod Revenue Market Share by Country in 2021
Figure 37. United States Iguratimod Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Iguratimod Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Iguratimod Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Iguratimod Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Iguratimod Sales Market Share by Region in 2021
Figure 42. APAC Iguratimod Revenue Market Share by Regions in 2021
Figure 43. China Iguratimod Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Iguratimod Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Iguratimod Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Iguratimod Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Iguratimod Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Iguratimod Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Iguratimod Sales Market Share by Country in 2021
Figure 50. Europe Iguratimod Revenue Market Share by Country in 2021
Figure 51. Germany Iguratimod Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Iguratimod Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Iguratimod Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Iguratimod Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Iguratimod Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Iguratimod Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Iguratimod Revenue Market Share by Country in 2021
Figure 58. Egypt Iguratimod Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Iguratimod Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Iguratimod Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Iguratimod Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Iguratimod Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Iguratimod in 2021
Figure 64. Manufacturing Process Analysis of Iguratimod
Figure 65. Industry Chain Structure of Iguratimod
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
